ProShares UltraShort MidCap400
5 hedge funds and large institutions have $552K invested in ProShares UltraShort MidCap400 in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
150% more funds holding
Funds holding: 2 → 5 (+3)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1.7% less ownership
Funds ownership: 29.13% → 27.43% (-1.7%)
25% less capital invested
Capital invested by funds: $736K → $552K (-$184K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$23.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$18.7K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$108 |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$84.3K |
MZZ Hedge Fund Activity: Q4 2023 in Review
5 of the 6,867 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort MidCap400 (MZZ) for Q4 2023, worth a combined $552K — down 25% from $736K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MZZ positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $23.6K. The largest seller was Tower Research Capital (TRC), cutting an estimated $84.3K.
- 5 institutional investors held ProShares UltraShort MidCap400 (MZZ) as of Q4 2023, up from 2 in Q3 2023.
- Funds reported $552K of ProShares UltraShort MidCap400 stock for Q4 2023, down 25% quarter-over-quarter.
- 3 funds opened new ProShares UltraShort MidCap400 positions in Q4 2023 and 0 closed out, a net change of +3 holders.
- The largest ProShares UltraShort MidCap400 buyer in Q4 2023 was UBS Group, an estimated $23.6K added.
- The largest ProShares UltraShort MidCap400 seller in Q4 2023 was Tower Research Capital (TRC), an estimated $84.3K sold.
Based on aggregated 13F filings for Q4 2023.